(PRECISION) A Phase II Study of the Optune System, Enhanced by Genomic Analysis to Identify the Genetic Signature of Response in the Treatment of Recurrent Glioblastoma Multiforme

Purpose

The purpose of this research study is to collect information on how people respond to treatment with Optune and to see if their response to treatment relates to the genetic make-up of their tumor. Each person who participates in this study will have tumor tissue and blood tested for genetic sequencing, meaning that the exact genetic code of the tumor and blood will be identified.

Eligibility

  • Disease: Brain tumor
  • Disease type: Recurrent Glioblastoma Multiforme (GBM)

For additional information about eligibility criteria, please contact the study coordinator Sonisha Warren: 

Age

N/A

Gender

Male
Female

Can be done from home

No

Keywords

Glioblastoma multiforme, Tumor, Brain tumor - primary - adults

Principal Investigator

David Tran, MD, PhD

Department

MD-NEUROLOGICAL SURGERY

Contact Information

sonisha.warren@neurosurgery.ufl.edu

352.294.8737


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams